Identification
Listing sponsor

Midcap Partners

Instrument name
SAFE ORTHOPAEDICS
Symbol
ALSAF
ISIN code
FR0012452746
Exchange / Market
Euronext Growth
Trading location
Paris
Products family
Stocks
ICB
Medical Equipment
Issuer website
www.safeorthopaedics.com
Operation
IPO date
IPO type

Direct Listing

Issue type
Transfer

Company profile

Safe Orthopaedics specializes in the design, manufacture and marketing of medical devices for spine surgery. The company offers implants and instruments in the range of SteriSpine (the first spinal arthrodesis system that is for single use and is sterile and totally traceable). Net sales break down by distribution channel as follows:
  • direct sale (61.5%): activity carried out in France, Germany and the United Kingdom;
  • indirect sale (38.5%).

Source: Cofisem - Last Update: 31 Jan 2020
Key Executives
Chairman and Chief Executive Officer Pierre Dumouchel
Administrative & Finance Director François-Henri Reynaud
Manager Katy Fraisse
Source: Cofisem - Last Update: 28 Nov 2019
Key figures
Millenium 2018 2017 2016 2015 2014
Net sales 3,471 3,110 2,365 2,498 2,053
Income from ordinary activities 3,471 3,110 2,385 2,532 2,053
Operating income -6,150 -5,434 -6,287 -7,218 -5,566
Cost (net) of financial indebtedness -23 -20 -37 2 25
Equity-accounted companies' contribution to results
Net profit from discontinued activities
Net income -5,800 -6,575 -6,005 -6,566 -4,936
Net income (Group share) -5,800 -6,575 -6,005 -6,566 -4,936
Fiscal year end 12.18 12.17 12.16 12.15 12.14
Length of fiscal year (month) 12 12 12 12 12
Currency & Unit EUR - thousands EUR - thousands EUR - thousands EUR - thousands EUR - thousands
Account Standards
Source: Cofisem - Last Update: 31 Jan 2020
Shareholder information
Ehgo Securitization Fund 38.26 %
Kurma Biofund 6.27 %
Keren Finance 4.80 %
IDinvest 4.23 %
Kisco 4.22 %
TLP European Investment 2.91 %
Founders 2.45 %
European High Growth Opportunities Manco 2.37 %
Kurma Partners 2.30 %
Employees 1.62 %
Invistm SAS 1.18 %
Yorkville Ocabsa 1.04 %
Michael DeMane 0.89 %
Alain Coudray 0.51 %
Pierre Dumouchel 0.33 %
Group-owned stock 0.10 %
Fred Goad 0.06 %
Marie Landel 0.04 %
Anne Reiser 0.01 %
Source: Cofisem - Last Update: 28 Aug 2019